Overcoming resistance to antibody-drug conjugates: mechanisms and emerging strategies.
Saved in:
| Title: | Overcoming resistance to antibody-drug conjugates: mechanisms and emerging strategies. |
|---|---|
| Authors: | Inase A; Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan.; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, 43210, United States., Kimbara S; Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan., Imamura E; Timele Clinic, Tokyo, 167-0022, Japan., Phelps MA; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, 43210, United States.; Pelotonia Institute for Immuno-Oncology, OSUCCC - James, The Ohio State University, Columbus, OH, 43210, United States.; The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, United States., Minami H; Division of Medical Oncology and Hematology, Department of Medicine, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan.; Cancer Center, Kobe University Hospital, Kobe, 650-0017, Japan. |
| Source: | The oncologist [Oncologist] 2026 Mar 09; Vol. 31 (4). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1549-490X |
|---|---|
| DOI: | 10.1093/oncolo/oyag020 |
